
About
Magali Irla obtained a PhD in immunology from Aix-Marseille University, where she studied a gene expressed by thymic epithelial cells (TECs) and developed an approach for gene transfer into the thymus. She then completed her postdoctoral fellowship in the laboratory of Prof. Walter Reith at the University of Geneva, Switzerland, thanks to a European EMBO grant. She made a major discovery concerning the development of bone marrow TECs, which control central tolerance, and studied the interactions between plasmacytoid dendritic cells (pDCs) and Foxp3+ Tregs in the context of central nervous system autoimmunity.
She was then promoted to junior team leader at the University of Geneva, where she studied the topology of the thymic medulla. She subsequently obtained a CR1 researcher position at Inserm and joined the CIML, while continuing to lead projects on thymus biology. In 2016, she obtained her accreditation to direct research (HDR).
In 2021, she created her research team at CIML and was promoted to research director at Inserm in 2022.
His laboratory is interested in T cell development and thymic function (Annu Rev Immunol. 2022). The team has made several major contributions in this field concerning: thymic dendritic cells (Nat Commun. 2018), TEC development (Elife. 2022), regeneration of thymic function after bone marrow transplantation (EMBO Mol Med. 2017) and during aging (Sci Transl Med. 2024), as well as the development of thymic Foxp3+ Tregs (Cell Mol Life Sci. 2022; Nat Commun. 2024).
In 2019, Magali Irla received the National Academy of Medicine prize for her translational research work.
Magali Irla is a member of the Specialized Scientific Commission “Immunology, Microbiology, Infection” (CSS5) at Inserm. She was also a member of the ANR CE18 “Biomedical Innovation” committee and actively participates in scientific evaluation at the national and international levels.
Projects
Project: Reality Foxp3+ regulatory T cells (Tregs) are crucial players in the control of autoimmune and inflammatory diseases […]

Project: SelfExpress The thymus plays a critical role in establishing central tolerance by producing a diverse repertoire […]

Project: ThymMap T lymphocytes recognize pathogens while being tolerant to our tissues. They differentiate […]

Project: T-ALL Leukemias T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive blood cancer, representing 25% of […]
